Ad blocking detected

Thank you for visiting CanadianInsider.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Ultra Club
$500/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads
JOIN THE CLUB

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

EGF Theramed Health Corp. (C:TMED)

Business Focus: Biotechnology & Medical Research (NEC)

Sector:  Healthcare Industry:  Biotechnology & Medical Research
 
Company Contact
Address: Suite 1600 - 609 Granville Street
Pacific Centre
P.O. Box 10068
VANCOUVER BC V7Y 1C3
Tel: N/A
Website: https://www.egftheramedhealth.com
IR: See website
Key People
N/A    
Business Overview
EGF Theramed Health Corp. is a Canada-based consumer technology company engaged in the provision of biomedical online services for monitoring and treating common health problems. The Company, through its subsidiaries, has assets and technologies used in the extraction and purification of botanical extracts and the creation of extract formulations, as well as medical monitoring device technology. The Company is working to collaborate with other companies for medical technology, equipment protocols and laboratory SOPs. The Company is focused on developing products, technologies, and diagnostic tools in personalized medical care areas, including research with natural health and wellness products. The Company is focused on the health care and life sciences sector to develop a personalized health care system. The Company is also exploring opportunities in all medical areas in domestic and international markets. Its portfolio includes Pharmadelic Labs and Green Parrot Labs.
Financial Overview
For the six months ended 31 December 2023, EGF Theramed Health Corp revenues was not reported. Net loss decreased 75% to C$102K. Lower net loss reflects Investor communications decrease from C$197K (expense) to C$0K, Professional fees decrease of 92% to C$6K (expense), Gain (loss) on foreign exchange increase from C$23K (expense) to C$1K (income). Basic Earnings per Share excluding Extraordinary Items increased from -C$0.04 to -C$0.01.
Reporting Currency: Canadian Dollars
Enterprise value: $2.90M as of Dec 31, 2023
Annual revenue (TTM): $0.00M as of Dec 31, 2023
EBITDA (TTM): -$0.29M as of Dec 31, 2023
Net annual income (TTM): -$0.32M as of Dec 31, 2023
Free cash flow (TTM): -$0.17M as of Dec 31, 2023
Net Debt Last Fiscal Year: $1.37M as of Dec 31, 2023
Shares outstanding: 11,391,161 as of Dec 31, 2023
TTM: Trailing Twelve Months
EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization